When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KURA - Kura Oncology says lymphoma treatment trial met primary endpoint
Kura Oncology Inc.
Kura Oncology (NASDAQ:KURA) +7.9% pre-market after announcing data from a phase 2 clinical trial of its tipifarnib drug candidate in patients with relapsed or refractory peripheral T-cell lymphoma.
More news on: Kura Oncology, Inc., Healthcare stocks news, Stocks on the move,